Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Net Debt Over TimeCompressed
Percentile Rank21
Studio
Year-over-Year Change

Total debt minus cash and cash equivalents

Latest
$-114.63M
↓ 48% vs avg
Percentile
P21
Within normal range
Streak
2 yr
Consecutive declineCompressed
Average
$-77.62M
Historical baseline
PeriodValueYoY Change
2025$-114.63M-99.6%
2024$-57.43M-47.2%
2023$-39.03M+73.3%
2022$-146.28M-2084.0%
2021$-6.70M+57.3%
2020$-15.67M-534.7%
2019$-2.47M+97.0%
2018$-82.15M+43.5%
2017$-145.37M+12.7%
2016$-166.47M-